Exact Sciences Corporation (EXAS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:36AM EDT. Market open.
| Previous close | 58.78 |
| Open | 58.00 |
| Bid | 59.18 x 200 |
| Ask | 59.57 x 100 |
| Day's range | 57.55 - 59.86 |
| 52-week range | 56.05 - 100.77 |
| Volume | |
| Avg. volume | 2,505,511 |
| Market cap | 10.9B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Exact Sciences (EXAS) closed at $63.24, marking a -0.46% move from the previous day.
- Insider Monkey
Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
- Zacks
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
Exact Sciences' (EXAS) first-quarter 2024 performance is expected to include gains from robust Cologuard uptake and continuing Oncotype DX growth, offset slightly by increasing operating costs.
© 2024 Yahoo. All rights reserved.